Where is the live CopyMark page for USPTO serial 79273062?

The live record is at https://getcopymark.com/trademark/79273062. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns Serial No. 79273062?

According to the public USPTO record for serial number 79273062, the listed owner(s) include: Noile-Immune Biotech, Inc., Noile-Immune Biotech, Inc., Noile-Immune Biotech, Inc..

What is USPTO serial number 79273062?

Serial number 79273062 is the USPTO application identifier for the mark Serial No. 79273062. It is used to track examination, publication, and registration of this trademark.

Which trademark classes cover Serial No. 79273062?

The public record lists International Classes: 005, 042, 045. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: Serial No. 79273062 Serial# 79273062 Reg# 6144293 | Section 8 declaration is in the USPTO grace period; file by Mar 8, 2027 | status 708; last event NA75 | Trademark Info & Attorney Guidance

Q: What is the current status of Serial No. 79273062?

Serial No. 79273062 (79273062) currently shows USPTO status code 708 on the public record. This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with Serial No. 79273062?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Get help with this Renewal, set up monitoring, or talk with CopyMark.

Get Attorney Assistance for just $748*

Plus Government fees of $850

Trademark Monitoring (312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Daniel M. Gurfinkel

Daniel M. Gurfinkel Dennemeyer & Associates, LLC230 W. Monroe St.Suite 2100Chicago, IL 60606

Goods and services

Class	Description	Status	First use
005	[ Pharmaceutical preparations and substances for the diagnosis, treatment and prevention of cancer and tumors; pharmaceutical preparations for the treatment of cancer and autoimmune diseases in the field of oncology; biological preparations for the treatment of cancer; biological tissue cultures for medical purposes; tumor suppressing agents; antitumor drugs; pharmaceutical preparations and vaccines for the treatment of cancer; antibodies for medical purposes ]	SECTION 71 - CANCELLED	—
042	Testing, inspection or research of pharmaceuticals and providing information, advice and consultancy relating thereto; research and development of medical technology and providing information relating thereto; conducting clinical trials for others; scientific research for medical purposes in the field of cancerous diseases and providing information relating thereto; research and development services in the field of immunology and providing information relating thereto; providing information in relation to clinical trials; designing of machines, apparatus, instruments including their parts, and systems composed of such machines, apparatus and instruments; consultancy in the design and development of computer hardware; computer software design, computer programming and maintenance of computer software; design and development of computer hardware and software for use in the field of medicine; research services in the field of proteins, antibodies, microorganisms and cells; research and development services in the field of antibodies	ACTIVE	—
045	Granting of licenses to others for the use of intellectual property rights	ACTIVE	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Oct 8, 2026	NA75	NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED	—
Oct 8, 2026	C75P	REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.	—
Oct 5, 2026	APRE	CASE ASSIGNED TO POST REGISTRATION PARALEGAL	—
Sep 8, 2026	ES75	TEAS SECTION 71 & 15 RECEIVED	—
Sep 8, 2025	REM3	COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED	—
Jan 15, 2021	FINO	FINAL DECISION TRANSACTION PROCESSED BY IB	—
Dec 29, 2020	FICS	FINAL DISPOSITION NOTICE SENT TO IB	—
Dec 29, 2020	FIMP	FINAL DISPOSITION PROCESSED	—
Dec 8, 2020	FICR	FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB	—
Sep 8, 2020	R.PR	REGISTERED-PRINCIPAL REGISTER	Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 23, 2020	NPUB	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	—
Jun 23, 2020	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 3, 2020	NONP	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	—
May 18, 2020	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
May 15, 2020	TEME	TEAS/EMAIL CORRESPONDENCE ENTERED	—
May 14, 2020	CRFA	CORRESPONDENCE RECEIVED IN LAW OFFICE	—
May 14, 2020	TROA	TEAS RESPONSE TO OFFICE ACTION RECEIVED	This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 1, 2020	RFNT	REFUSAL PROCESSED BY IB	—
Jan 11, 2020	RFCS	NON-FINAL ACTION MAILED - REFUSAL SENT TO IB	—
Jan 11, 2020	RFRR	REFUSAL PROCESSED BY MPU	—
Dec 12, 2019	RFCR	NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW	—
Dec 11, 2019	CNRT	NON-FINAL ACTION WRITTEN	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 9, 2019	DOCK	ASSIGNED TO EXAMINER	—
Dec 6, 2019	MAFR	APPLICATION FILING RECEIPT MAILED	—
Dec 2, 2019	NWOS	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED	—
Nov 28, 2019	REPR	SN ASSIGNED FOR SECT 66A APPL FROM IB	—

Serial No. 79273062